Status
Conditions
About
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
1,500 participants in 3 patient groups
Loading...
Central trial contact
George Lau, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal